Selected research
Industry Research
Liranaftate Industry Research Report 2026
Market perspective
The global Liranaftate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Liranaftate market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Liranaftate market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Liranaftate market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Liranaftate include Zenyaku Kogyo Company, Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd, Nanjing Changao Pharmaceutical Co. Ltd, Tianfang Pharmaceutical Co., Ltd, Yangzijiang Pharmaceutical Group Co. Ltd and Zhejiang Wansheng Pharmaceutical Co. Ltd, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Liranaftate market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Liranaftate.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Liranaftate Market by Company
Zenyaku Kogyo Company
Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
Nanjing Changao Pharmaceutical Co. Ltd
Tianfang Pharmaceutical Co., Ltd
Yangzijiang Pharmaceutical Group Co. Ltd
Zhejiang Wansheng Pharmaceutical Co. Ltd
Liranaftate Segment by Type
Cream
Spray
Liranaftate Segment by Application
Tinea Pedis
Jock Itch
Liranaftate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liranaftate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liranaftate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liranaftate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Liranaftate companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cream
- Spray
Applications
- Tinea Pedis
- Jock Itch
Companies covered
- Zenyaku Kogyo Company
- Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
- Nanjing Changao Pharmaceutical Co. Ltd
- Tianfang Pharmaceutical Co., Ltd
- Yangzijiang Pharmaceutical Group Co. Ltd
- Zhejiang Wansheng Pharmaceutical Co. Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Liranaftate by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cream
- 2.2.3 Spray
- 2.3 Liranaftate by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Tinea Pedis
- 2.3.3 Jock Itch
- 2.4 Assumptions and Limitations
3 Liranaftate Breakdown Data by Type
- 3.1 Global Liranaftate Historic Market Size by Type (2021-2026)
- 3.2 Global Liranaftate Forecasted Market Size by Type (2027-2032)
4 Liranaftate Breakdown Data by Application
- 4.1 Global Liranaftate Historic Market Size by Application (2021-2026)
- 4.2 Global Liranaftate Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Liranaftate Market Perspective (2021-2032)
- 5.2 Global Liranaftate Growth Trends by Region
- 5.2.1 Global Liranaftate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Liranaftate Historic Market Size by Region (2021-2026)
- 5.2.3 Liranaftate Forecasted Market Size by Region (2027-2032)
- 5.3 Liranaftate Market Dynamics
- 5.3.1 Liranaftate Industry Trends
- 5.3.2 Liranaftate Market Drivers
- 5.3.3 Liranaftate Market Challenges
- 5.3.4 Liranaftate Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Liranaftate Players by Revenue
- 6.1.1 Global Top Liranaftate Players by Revenue (2021-2026)
- 6.1.2 Global Liranaftate Revenue Market Share by Players (2021-2026)
- 6.2 Global Liranaftate Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Liranaftate Head Office and Area Served
- 6.4 Global Liranaftate Players, Product Type & Application
- 6.5 Global Liranaftate Manufacturers Established Date
- 6.6 Global Liranaftate Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Liranaftate Market Size (2021-2032)
- 7.2 North America Liranaftate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Liranaftate Market Size by Country (2021-2026)
- 7.4 North America Liranaftate Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Liranaftate Market Size (2021-2032)
- 8.2 Europe Liranaftate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Liranaftate Market Size by Country (2021-2026)
- 8.4 Europe Liranaftate Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Liranaftate Market Size (2021-2032)
- 9.2 Asia-Pacific Liranaftate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Liranaftate Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Liranaftate Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Liranaftate Market Size (2021-2032)
- 10.2 South America Liranaftate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Liranaftate Market Size by Country (2021-2026)
- 10.4 South America Liranaftate Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Liranaftate Market Size (2021-2032)
- 11.2 Middle East & Africa Liranaftate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Liranaftate Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Liranaftate Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Zenyaku Kogyo Company
- 12.1.1 Zenyaku Kogyo Company Company Information
- 12.1.2 Zenyaku Kogyo Company Business Overview
- 12.1.3 Zenyaku Kogyo Company Revenue in Liranaftate Business (2021-2026)
- 12.1.4 Zenyaku Kogyo Company Liranaftate Product Portfolio
- 12.1.5 Zenyaku Kogyo Company Recent Developments
- 12.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
- 12.2.1 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Company Information
- 12.2.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Business Overview
- 12.2.3 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Revenue in Liranaftate Business (2021-2026)
- 12.2.4 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Product Portfolio
- 12.2.5 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Recent Developments
- 12.3 Nanjing Changao Pharmaceutical Co. Ltd
- 12.3.1 Nanjing Changao Pharmaceutical Co. Ltd Company Information
- 12.3.2 Nanjing Changao Pharmaceutical Co. Ltd Business Overview
- 12.3.3 Nanjing Changao Pharmaceutical Co. Ltd Revenue in Liranaftate Business (2021-2026)
- 12.3.4 Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Product Portfolio
- 12.3.5 Nanjing Changao Pharmaceutical Co. Ltd Recent Developments
- 12.4 Tianfang Pharmaceutical Co., Ltd
- 12.4.1 Tianfang Pharmaceutical Co., Ltd Company Information
- 12.4.2 Tianfang Pharmaceutical Co., Ltd Business Overview
- 12.4.3 Tianfang Pharmaceutical Co., Ltd Revenue in Liranaftate Business (2021-2026)
- 12.4.4 Tianfang Pharmaceutical Co., Ltd Liranaftate Product Portfolio
- 12.4.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
- 12.5 Yangzijiang Pharmaceutical Group Co. Ltd
- 12.5.1 Yangzijiang Pharmaceutical Group Co. Ltd Company Information
- 12.5.2 Yangzijiang Pharmaceutical Group Co. Ltd Business Overview
- 12.5.3 Yangzijiang Pharmaceutical Group Co. Ltd Revenue in Liranaftate Business (2021-2026)
- 12.5.4 Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Product Portfolio
- 12.5.5 Yangzijiang Pharmaceutical Group Co. Ltd Recent Developments
- 12.6 Zhejiang Wansheng Pharmaceutical Co. Ltd
- 12.6.1 Zhejiang Wansheng Pharmaceutical Co. Ltd Company Information
- 12.6.2 Zhejiang Wansheng Pharmaceutical Co. Ltd Business Overview
- 12.6.3 Zhejiang Wansheng Pharmaceutical Co. Ltd Revenue in Liranaftate Business (2021-2026)
- 12.6.4 Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Product Portfolio
- 12.6.5 Zhejiang Wansheng Pharmaceutical Co. Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst